Skip to main content
Portrait of Raj Kasthuri, MD

September 20, 2024

Dr. Kasthuri & Team Publish Study Evaluating the Safety and Efficacy of Pomalidomide for the Treatment of HHT in NEJM

Raj Kasthuri, MBBS, professor in the UNC Division of Hematology and director of the UNC HHT Center of Excellence, and a team of researchers published their study evaluating the safety and efficacy of pomalidomide for the treatment of Hereditary Hemorrhagic Telangiectasias in the New England Journal of Medicine.  Hereditary Hemorrhagic Telangiectasias (HHT) is an inherited …